Reuters logo
BRIEF-Ionis Pharma, ‍Dynacure announces Dynacure has licensed IONIS-DNM2-2.5(Rx) (Dyn101)​
November 9, 2017 / 12:42 PM / a month ago

BRIEF-Ionis Pharma, ‍Dynacure announces Dynacure has licensed IONIS-DNM2-2.5(Rx) (Dyn101)​

Nov 9 (Reuters) - Ionis Pharmaceuticals Inc

* Ionis Pharmaceuticals Inc - co, ‍Dynacure announced that Dynacure has licensed IONIS-DNM2-2.5(Rx) (Dyn101)​

* Ionis Pharmaceuticals Inc - ‍Dynacure will now assume all development and commercialization responsibilities for program​

* Ionis Pharmaceuticals Inc - ‍Ionis is eligible to receive additional cash or equity of up to more than $205 million in milestone payments​

* Ionis Pharmaceuticals Inc - ‍Ionis is eligible to receive royalties on future product sales of drug under this collaboration​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below